IP Library › Granted Patent US 8,337,876
Granted Patent B2
US 8,337,876 · App. 12/832,391 · Granted Dec 25, 2012

Devices and methods for tissue engineering

Assignee: Bio2 Technologies, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,337,876
App. No.
12/832,391
Granted
Dec 25, 2012
Kind
B2
Abstract

A resorbable tissue scaffold fabricated from bioactive glass fiber forms a rigid three-dimensional porous matrix having a bioactive composition. Porosity in the form of interconnected pore space is provided by the space between the bioactive glass fiber in the porous matrix. Strength of the bioresorbable matrix is provided by bioactive glass that fuses and bonds the bioactive glass fiber into the rigid three-dimensional matrix. The resorbable tissue scaffold supports tissue in-growth to provide osteoconductivity as a resorbable tissue scaffold, used for the repair of damaged and/or diseased bone tissue.

Claims (25)

1. A resorbable three-dimensional tissue scaffold comprising:

bioactive glass fibers;

bioactive glass bonding to at least a portion of the bioactive glass fibers; and

pore space within the three-dimensional tissue scaffold by volatile components removed during the bioactive glass bonding to the bioactive glass fibers,

wherein the pore space creates a porosity between about 40% and about 85% in the resorbable three-dimensional tissue scaffold.

2. tissue scaffold according to claim 1 wherein the pore space within the three-dimensional tissue scaffold has a pore size between about 100 μm and about 500 μm.

3. The tissue scaffold according to claim 2 wherein the pore size has a bi-modal size distribution.

4. The tissue scaffold according to claim 1 wherein a plurality of the bioactive glass fibers are bonded to adjacent bioactive glass fibers providing bundles of bonded bioactive glass fibers.

5. The tissue scaffold according to claim 1 wherein the bioactive glass fibers comprise sodium carbonate, calcium carbonate, phosphorus pentoxide, about 45 mol % to about 60 mol % silica, and an about 2 to an about 10 molar ratio of calcium to phosphate.

6. The tissue scaffold according to claim 1 wherein the bioactive glass fibers comprise glass fiber having a composition in respective mol % quantities of 6% Na 2 O; 7.9% K 2 O; 7.7% MgO; 22.1% CaO; 0% B 2 O 3 ; 1.7% P 2 O 5 ; and 54.6% SiO 2 .

7. The tissue scaffold according to claim 1 wherein the bioactive glass fibers have a diameter ranging from about 1 μm to about 200 μm.

8. The tissue scaffold according to claim 7 wherein the bioactive glass fibers have a diameter ranging from about 5 μm to about 100 μm.

9. A bioactive tissue scaffold comprising:

a rigid three-dimensional matrix of a bioactive composition formed from a process comprising:

mixing a bioactive fiber, a binder, a bioactive glass powder bonding agent, a pore former, and a liquid into a plastically formable batch;

forming the plastically formable batch into a shaped object;

drying the shaped object to remove the liquid;

removing the binder;

removing the pore former; and

heating the shaped object to fuse and bond the bioactive fiber into the rigid three-dimensional matrix using the bioactive glass powder bonding agent with pore space defined by the pore former.

10. The bioactive tissue scaffold according to claim 9 wherein the bioactive glass powder bonding agent is the same composition as the bioactive fiber.

11. The bioactive tissue scaffold according to claim 9 wherein the bioactive fiber comprises sodium carbonate, calcium carbonate, phosphorus pentoxide, about 45 mol % to about 60 mol % silica and an about 2 to an about 10 molar ratio of calcium to phosphate.

12. The bioactive tissue scaffold according to claim 9 wherein the bioactive fiber comprises a mixture of bioactive fiber having different compositions.

13. The bioactive tissue scaffold according to claim 9 wherein the bioactive glass powder bonding agent has a particle size between about 1 to about 1000 times smaller than the diameter of the bioactive glass fiber.

14. The bioactive tissue scaffold according to claim 9 wherein the pore former has a particle size between about 0.1 and about 100 times the bioactive fiber diameter.

Assignments (4)
SECURITY INTEREST Recorded Dec 3, 2021
From: NOVUM MEDICAL, INC.
To: DSM VENTURING B.V.
Reel/Frame 058283/0638 →
CHANGE OF NAME Recorded Apr 8, 2021
From: BIO2 TECHNOLOGIES, INC.
To: NOVUM MEDICAL, INC.
Reel/Frame 055872/0900 →
SECURITY INTEREST Recorded Dec 8, 2020
From: BIO2 TECHNOLOGIES, INC.
To: DSM VENTURING B.V.
Reel/Frame 054577/0284 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 22, 2010
From: LIU, JAMES J.; WALLEN, ADAM; NUUTINEN, JUHA-PEKKA
To: BIO2 TECHNOLOGIES, INC.
Reel/Frame 024727/0347 →
Continuity (3)
Provisional Application 61224675 · Jul 10, 2009
Provisional Application 61234768 · Aug 18, 2009
Related Publication 20110106255A1 · May 5, 2011